Startup Tests Drugs Aimed at Autism

An anonymous reader sends in this link from Technology Review about a startup company testing drugs that may help those with autism-spectrum disorders — even adults. "Seaside Therapeutics, a startup based in Cambridge, MA, is testing two compounds for the treatment of fragile X syndrome, a rare, inherited form of intellectual disability linked to autism. The treatments have emerged from molecular studies of animal models that mirror the genetic mutations seen in humans. Researchers hope that the drugs, which are designed to correct abnormalities at the connections between neurons, will ultimately prove effective in other forms of autism spectrum disorders. ... The company is funded almost entirely by an undisclosed family investment of $60 million, with $6 million from the National Institutes of Health. [A spokesman] says that Seaside has enough funding to take its compounds through clinical testing and approval."

Re:What if

[scapermoya]

what if what you think is red is actually blue to me lol!

Re:What if

[Gerafix]

No wonder you posted anon, that's an incoherent statement! You might as well say, "If today's dead was normal, then today's living would be called dead. Objectively, we are all dead and living at the same time really." Because life and death is merely a definition. I'm sure you understand that only works for cats in boxes.

THIS JUST IN

[RoFLKOPTr]

Autism vaccine is linked to flu in children. News at 11.